UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

The Journal of urology, 2017-09, Vol.198 (3), p.552

2017

Link zum Volltext

Verfügbarkeit prüfen

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

The New England journal of medicine, 2015-08, Vol.373 (8), p.737-746

2015

Link zum Volltext

Verfügbarkeit prüfen

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087

2018

Link zum Volltext

Verfügbarkeit prüfen

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

The Journal of urology, 2021-01, Vol.205 (1), p.14

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2432-2438

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2018-04, Vol.36 (10), p.1020-1044

2018

Link zum Volltext

Verfügbarkeit prüfen

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

Clinical cancer research, 2009-03, Vol.15 (6), p.2148-2157

2009

Link zum Volltext

Verfügbarkeit prüfen

Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

Clinical cancer research, 2008-10, Vol.14 (20), p.6674-6682

2008

Link zum Volltext

Verfügbarkeit prüfen

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

Journal of clinical oncology, 2008-03, Vol.26 (7), p.1148-1159

2008

Link zum Volltext

Verfügbarkeit prüfen

New mitomycin formulation for low-grade upper tract urothelial cancer

The lancet oncology, 2020-06, Vol.21 (6), p.735-736

Dreicer, Robert

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233

International journal of radiation oncology, biology, physics, 2016-01, Vol.94 (1), p.67-74

2016

Link zum Volltext

Verfügbarkeit prüfen

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings

European urology, 2013-01, Vol.63 (1), p.58-66

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for advanced urothelial cancer: end of the beginning?

The lancet oncology, 2017-05, Vol.18 (5), p.567-569

Dreicer, Robert

2017

Link zum Volltext

Verfügbarkeit prüfen

EDITORIAL COMMENT

Urology (Ridgewood, N.J.), 2019-09, Vol.131, p.182

Dreicer, Robert

2019

Link zum Volltext

Verfügbarkeit prüfen

Prospective Clinical Study of Precision Oncology in Solid Tumors

JNCI : Journal of the National Cancer Institute, 2016-03, Vol.108 (3), p.1

2016

Link zum Volltext

Verfügbarkeit prüfen

Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

Cancer, 2010-06, Vol.116 (12), p.2967-2973

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

Urologic oncology, 2016-12, Vol.34 (12), p.530.e15-530.e21

2016

Link zum Volltext

Verfügbarkeit prüfen

New option for cisplatin-ineligible urothelial cancer

The lancet oncology, 2017-11, Vol.18 (11), p.1428-1430

Dreicer, Robert

2017

Link zum Volltext

Verfügbarkeit prüfen

The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery

The Journal of urology, 2012-05, Vol.187 (5), p.1548

2012

Link zum Volltext

Verfügbarkeit prüfen

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

JAMA oncology, 2020-04, Vol.6 (4), p.e196496

2020

Link zum Volltext

Verfügbarkeit prüfen

Systemic Chemotherapy for Advanced Bladder Cancer: Update and Controversies

Journal of clinical oncology, 2006-12, Vol.24 (35), p.5545-5551

2006

Link zum Volltext

Verfügbarkeit prüfen

Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators

Journal of clinical oncology, 2007-02, Vol.25 (6), p.669-674

2007

Link zum Volltext

Verfügbarkeit prüfen

CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment

Journal of experimental & clinical cancer research, 2023-03, Vol.42 (1), p.1-61, Article 61

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(382)
Mit Volltextzugriff
(362)

Publikationsform

Sprache

Englisch
(397)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Humans
(213)
Science & Technology
(199)
Life Sciences & Biomedicine
(196)
Male
(171)
Oncology
(144)
Middle Aged
(118)
Aged
(116)
Biological And Medical Sciences
(91)
Medical Sciences
(91)
Female
(73)
Treatment Outcome
(68)
Urology & Nephrology
(61)
Adult
(58)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(56)
Aged, 80 And Over
(55)
Chemotherapy
(54)
Tumors
(51)
Nephrology. Urinary Tract Diseases
(49)
Prostatic Neoplasms - Drug Therapy
(48)
Prostate Cancer
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy

Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients

Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

New mitomycin formulation for low-grade upper tract urothelial cancer

Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings

Chemotherapy for advanced urothelial cancer: end of the beginning?

Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer

EDITORIAL COMMENT

Prospective Clinical Study of Precision Oncology in Solid Tumors

Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

New option for cisplatin-ineligible urothelial cancer

The effect of sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Systemic Chemotherapy for Advanced Bladder Cancer: Update and Controversies

Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators

CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment

Suchergebnisse filtern